OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Naringenin in combination with quercetin/fisetin shows synergistic anti-proliferative and migration reduction effects in breast cancer cell lines
Masoume Jalalpour Choupanan, Shahrzad Shahbazi, Somayeh Reiisi
Molecular Biology Reports (2023) Vol. 50, Iss. 9, pp. 7489-7500
Closed Access | Times Cited: 4
Masoume Jalalpour Choupanan, Shahrzad Shahbazi, Somayeh Reiisi
Molecular Biology Reports (2023) Vol. 50, Iss. 9, pp. 7489-7500
Closed Access | Times Cited: 4
Showing 4 citing articles:
Naringenin as potent anticancer phytocompound in breast carcinoma: from mechanistic approach to nanoformulations based therapeutics
Deena Elsori, Pratibha Pandey, Seema Ramniwas, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Deena Elsori, Pratibha Pandey, Seema Ramniwas, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Therapeutic Efficacy of Quercetin and Its Nanoformulation Both the Mono‐ or Combination Therapies in the Management of Cancer: An Update with Molecular Mechanisms
Tanzila Akter Eity, Md. Shimul Bhuia, Raihan Chowdhury, et al.
Journal of Tropical Medicine (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 3
Tanzila Akter Eity, Md. Shimul Bhuia, Raihan Chowdhury, et al.
Journal of Tropical Medicine (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 3
Oxidative lipid damage by naringenin selectively sensitizes chronic myeloid leukemia cell lines and patient samples to Bcr-Abl tyrosine kinase inhibitors
Ming Wang, Qiuyuan Deng, Wei Zhang, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 733, pp. 150653-150653
Closed Access
Ming Wang, Qiuyuan Deng, Wei Zhang, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 733, pp. 150653-150653
Closed Access
Multidisciplinary examples of applications: Papers using the MAL-PD/BD/CI/BI theory/method
Ting-Chao Chou
Elsevier eBooks (2024), pp. 181-218
Closed Access
Ting-Chao Chou
Elsevier eBooks (2024), pp. 181-218
Closed Access
